Next, we evaluated whether SKP2 promoted tumor growth by subcutaneously engrafting JR1 cells expressing shSKP2.1, shSKP2.2, or scrambled shRNA (shSCR) as control. The gene discussed is SKP2; the disease is neoplasm.